26 Drug
Formulations Export Shifted from Free to Restricted List
[DGFT
Notification No. 50/2015-2020 dated 3 March 2020]
Effect of
this Notification: Export of specified APIs (Active Pharmaceutical
Ingredients) and formulations made from these APIs under the ITC HS Codes
mentioned against each is hereby ‘restricted’, with immediate effect and till
further orders.
Subject: – Amendment
in Export Policy of APIs and formulations made from these APIs
In exercise of powers conferred by Section 3 of the Foreign Trade (Development
& Regulation) Act, 1992 (No. 22 of 1992), as amended. read with Para 1.02 and
2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes amendment,
with immediate effect in Chapter 29(Organic Chemicals) and Chapter 30 (Pharmaceutical)
of the Schedule 2 of the ITC (HS) Export Policy 2018, by inclusion of items, as
indicated in the Table below:
|
S.No |
ITC HS
Codes |
Description |
Present
Policy |
Revised
Policy |
|
146A |
29222933 |
Paracetamol |
Free |
Restricted |
|
146B |
29332910 |
Tinidazole |
|
|
|
146C |
29332920 |
Metronidazole |
|
|
|
146D |
29335990 |
Acyclovir |
|
|
|
146E |
29362210 |
Vitamin
B1 |
|
|
|
146F |
29362500 |
Vitamin
B6 |
|
|
|
146G |
29362610 |
Vitamin
B12 |
|
|
|
146H |
29372300 |
Progesterone |
|
|
|
146I |
29414000 |
Chloramphenicol |
|
|
|
146 |
29415000 |
Erythromycin
Salts |
|
|
|
146K |
29419050 |
Neomycin |
|
|
|
146L |
29419090 |
Clindamycin
Salts |
|
|
|
146M |
29420090 |
Ornidazole |
|
|
|
156A |
30042050 |
Formulations
made of Chloramphenicol |
|
|
|
156B |
30042061 |
Formulations
made of Erythromycin Salts |
|
|
|
156C |
30042095 |
Formulations
made or Clindamycin Salts |
|
|
|
156D |
30043919 |
Formulations
made of Progesterone |
|
|
|
156E |
30045032 |
Formulations
made of Vitamin B1 |
|
|
|
156F |
30045032 |
Formulations
made of Vitamin B12 |
|
|
|
156G |
30045039 |
Formulations
made of Vitamin B6 |
|
|
|
156H |
30049015 |
Formulations
made of Neomycin |
|
|
|
156I |
30049021 |
Formulations
made of Ornidazole |
|
|
|
156J |
30049022 |
Formulations
made of Metronidazole |
|
|
|
156K |
30049023 |
Formulations
made of Tinidazole |
|
|
|
156L |
30049099 |
Formulations
made of Acyclovir |
|
|
|
156M |
30049099 |
Formulations
made of Paracetamol |
|
|
(Issued
from File No. 01/91/180/24/AM20/EC)